Roche Holding AG Net Worth 2006-2020 | RHHBY

Interactive chart of historical net worth (market cap) for Roche Holding AG (RHHBY) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Roche Holding AG net worth as of September 17, 2021 is $314.66B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $314.658B $64.542B
Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. The Company distributes its products throughout Europe, the United States, Asia and Latin America.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $433.701B 18.05
Pfizer (PFE) United States $246.078B 13.98
Novo Nordisk (NVO) Denmark $238.800B 33.14
Eli Lilly (LLY) United States $220.672B 28.66
AbbVie (ABBV) United States $190.378B 9.12
Novartis AG (NVS) Switzerland $186.723B 13.87
Merck (MRK) United States $181.449B 12.42
AstraZeneca (AZN) United Kingdom $172.138B 24.48
Sanofi (SNY) $121.994B 13.44
GlaxoSmithKline (GSK) United Kingdom $104.823B 13.15
Bayer (BAYRY) Germany $52.226B 7.03
H Lundbeck (HLUYY) Denmark $5.356B 10.27
Innoviva (INVA) United States $1.088B 5.84